Directional local field potentials: A tool to optimize deep brain stimulation

Background: Although recently introduced directional DBS leads provide control of the stimulation field, programing is time‐consuming.

[1]  Peter Brown,et al.  Intra-operative recordings of local field potentials can help localize the subthalamic nucleus in Parkinson's disease surgery , 2006, Experimental Neurology.

[2]  John Seibyl,et al.  Dopamine agonists and Parkinson's disease progression: What can we learn from neuroimaging studies , 2003, Annals of neurology.

[3]  Daniel Strickland,et al.  Parkinson's prevalence estimated by a state registry , 2004, Movement disorders : official journal of the Movement Disorder Society.

[4]  Michael S. Okun,et al.  Coordinate-Based Lead Location Does Not Predict Parkinson's Disease Deep Brain Stimulation Outcome , 2014, PloS one.

[5]  Bettina Schrader,et al.  Most effective stimulation site in subthalamic deep brain stimulation for Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[6]  J. Thiran,et al.  Localization of electrodes in the subthalamic nucleus on magnetic resonance imaging. , 2007, Journal of neurosurgery.

[7]  Lorene M Nelson,et al.  Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. , 2003, American journal of epidemiology.

[8]  D. Maraganore,et al.  Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990 , 1999, Neurology.

[9]  A. Lozano,et al.  Directional deep brain stimulation: an intraoperative double-blind pilot study. , 2014, Brain : a journal of neurology.

[10]  Nuri Firat Ince,et al.  Selection of Optimal Programming Contacts Based on Local Field Potential Recordings From Subthalamic Nucleus in Patients With Parkinson's Disease , 2010, Neurosurgery.

[11]  L. Timmermann,et al.  Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study , 2015, The Lancet Neurology.

[12]  A. Lang,et al.  Factors influencing the outcome of deep brain stimulation: Placebo, nocebo, lessebo, and lesion effects , 2016, Movement disorders : official journal of the Movement Disorder Society.

[13]  H. Davies,et al.  When can odds ratios mislead? , 1998, BMJ.

[14]  G. Schneider,et al.  Toward an electrophysiological “sweet spot” for deep brain stimulation in the subthalamic nucleus , 2017, Human brain mapping.

[15]  J. Volkmann,et al.  Basic algorithms for the programming of deep brain stimulation in Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[16]  G. Deuschl,et al.  Neurostimulation for Parkinson's disease with early motor complications. , 2013, The New England journal of medicine.

[17]  E. Feuer,et al.  Patterns of birth cohort-specific smoking histories, 1965-2009. , 2014, American journal of preventive medicine.

[18]  W. Rocca,et al.  Time Trends in the Incidence of Parkinson Disease. , 2016, JAMA neurology.

[19]  Marina Picillo,et al.  Programming Deep Brain Stimulation for Parkinson's Disease: The Toronto Western Hospital Algorithms , 2016, Brain Stimulation.

[20]  R. Holloway,et al.  Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries , 2006, Movement disorders : official journal of the Movement Disorder Society.

[21]  G. Foffani,et al.  Directional local field potential recordings for symptom‐specific optimization of deep brain stimulation , 2017, Movement disorders : official journal of the Movement Disorder Society.

[22]  D. Jennings,et al.  Can we image premotor Parkinson disease? , 2009, Neurology.

[23]  D. Morens,et al.  Epidemiologic observations on Parkinson's disease , 1996, Neurology.

[24]  R. Raedt,et al.  The Effect of Vagus Nerve Stimulation on CSF Monoamines and the PTZ Seizure Threshold in Dogs , 2015, Brain Stimulation.

[25]  Peter Brown,et al.  Value of subthalamic nucleus local field potentials recordings in predicting stimulation parameters for deep brain stimulation in Parkinson's disease , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[26]  Elena Moro,et al.  Subthalamic nucleus stimulation: improvements in outcome with reprogramming. , 2006, Archives of neurology.

[27]  C. Tanner,et al.  Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 , 2007, Neurology.

[28]  Dallas W. Anderson,et al.  Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi , 1985, Neurology.

[29]  Lars Timmermann,et al.  Directional deep brain stimulation: A case of avoiding dysarthria with bipolar directional current steering. , 2016, Parkinsonism & related disorders.

[30]  T. Dall,et al.  The current and projected economic burden of Parkinson's disease in the United States , 2013, Movement disorders : official journal of the Movement Disorder Society.

[31]  Hilla Peretz,et al.  Ju n 20 03 Schrödinger ’ s Cat : The rules of engagement , 2003 .

[32]  Jens Volkmann,et al.  Innovations in deep brain stimulation methodology , 2017, Movement disorders : official journal of the Movement Disorder Society.

[33]  R. Mailman,et al.  Smoking duration, intensity, and risk of Parkinson disease , 2010, Neurology.

[34]  M. F. Contarino,et al.  Directional Recording of Subthalamic Spectral Power Densities in Parkinson's Disease and the Effect of Steering Deep Brain Stimulation , 2015, Brain Stimulation.

[35]  F. Speizer,et al.  Cigarette smoking and the incidence of Parkinson's disease in two prospective studies , 2001, Annals of neurology.

[36]  D. Huse,et al.  Burden of illness in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[37]  PharmD,et al.  Economic Burden Associated With Parkinson Disease , 2009 .

[38]  J. Volkmann,et al.  Directional deep brain stimulation of the subthalamic nucleus: A pilot study using a novel neurostimulation device , 2016, Movement disorders : official journal of the Movement Disorder Society.

[39]  A. Paganini-Hill.  Risk Factors for Parkinson’s Disease: The Leisure World Cohort Study , 2001, Neuroepidemiology.

[40]  A. Ascherio,et al.  Variations in gender ratios support the connection between smoking and Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[41]  Hagai Bergman,et al.  Subthalamic span of beta oscillations predicts deep brain stimulation efficacy for patients with Parkinson's disease. , 2010, Brain : a journal of neurology.

[42]  Miguel A Hernán,et al.  A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease , 2002, Annals of neurology.

[43]  K. Marder,et al.  The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. , 1995, American journal of epidemiology.

[44]  T. Bodenheimer,et al.  Confronting the growing burden of chronic disease: can the U.S. health care workforce do the job? , 2009, Health affairs.

[45]  M. Thun,et al.  Temporal relationship between cigarette smoking and risk of Parkinson disease , 2007, Neurology.

[46]  Eric Panken,et al.  Guiding deep brain stimulation contact selection using local field potentials sensed by a chronically implanted device in Parkinson's disease patients , 2015, 2015 7th International IEEE/EMBS Conference on Neural Engineering (NER).

[47]  E. Dorsey,et al.  Nursing home and end-of-life care in Parkinson disease , 2015, Neurology.